Invitrogen™ Kit ELISA d的IL-1 beta porcine

Ref.: BL-RE-091044Manufacturer ref.: ESIL1BX10 10 x 96 tests
€4,815.00 excl. VAT

The interleukin-1 beta is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. L的IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive proform that is...

Accession number
P26889
Dose range
8.23 to 6.000 pg/ml
Sensitivity of the dosage
6 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

The interleukin-1 beta is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. L的IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive proform that is...

The interleukin-1 beta is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. L的IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive proform that accumulates in cytosol. The cleavage of pro-IL-1 beta in the active 17 kDa protein requires the activation of inflammasomas, which are multiprotein complexes that respond to pathogens, stress conditions and other hazard signals. Activation of the inflammasoma triggers the treatment of the precursor of caspase-1 in its active form, which in turn cleaves the pro-IL-1 beta. L的IL-1 beta does not have a signal sequence peptide for the conventional ER/Golgi pathway. It is secreted along the caspase-1 via an alternative mechanism and understood incompletely. Although the beta-IL-1 is most often secreted as active, the secretion of the uncleavened protein can be detectable under certain biological conditions. The signals of the IL-1 beta via two receptors, IL-1RI and IL-1RII, are both shared with l的IL-1 alpha. The activity of the IL-1 beta may be moderated by the IL-1 receptor antagonist, a protein produced by many types of cells that block receptor binding by competitive inhibition. The role of the beta-IL-1 is important in the defence of the innate host by triggering the production of other proinflammatory cytokines in the target cells and by triggering acute phase responses to infection and injury. High levels of d的IL-1 beta have been associated with many chronic inflammatory conditions of the beta-IL-1 neutralizing the potential therapeutic value of antibodies.

Sensitivity

Sensitivity of the dosage: 6 pg/ml.

Measurement range

Dose range: 8.23 to 6.000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: IL-1 beta.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17728293
Specifications
Accession numberP26889
Dose range8.23 to 6.000 pg/ml
Sensitivity of the dosage6 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)397122
Gene symbol(s)IL1B
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetIL-1 beta
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 μl-Serum, 50 μl-Surnatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ESIL1BX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.